United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024
SKU ID : DPI-11349318 | Publishing Date : 16-Oct-2017 | No. of pages : 115
Detailed TOC of United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024
1. Executive Summary 2. Market Size & Analysis: United States Pediatric Vaccine (2010 – 2024) 3. United States Pediatric Vaccine Market Share and Y–o–Y Growth (%) 4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccine Market 4.1 Market Drivers 4.2 Market Inhibitors 5. United States Pediatric Vaccine Market – By Disease Indication (2010 – 2024) 5.1 Diphtheria, Tetanus & Pertussis (DTap) 5.1.1 Doses Administered (Volume) 5.1.2 Number of Children Being Vaccinated (Volume) 5.1.3 Market Size and Forecast (Value) 5.2 Hepatitis A 5.2.1 Doses Administered (Volume) 5.2.2 Number of Children Being Vaccinated (Volume) 5.2.3 Market Size and Forecast (Value) 5.3 Varicella / Chicken Pox 5.3.1 Doses Administered (Volume) 5.3.2 Number of Children Being Vaccinated (Volume) 5.3.3 Market Size and Forecast (Value) 5.4 Pneumococcal 5.4.1 Doses Administered (Volume) 5.4.2 Number of Children Being Vaccinated (Volume) 5.4.3 Market Size and Forecast (Value) 5.5 Haemophilus Influenzae Type B (HIB) 5.5.1 Doses Administered (Volume) 5.5.2 Number of Children Being Vaccinated (Volume) 5.5.3 Market Size and Forecast (Value) 5.6 Polio 5.6.1 Doses Administered (Volume) 5.6.2 Number of Children Being Vaccinated (Volume) 5.6.3 Market Size and Forecast (Value) 5.7 Rotavirus 5.7.1 Doses Administered (Volume) 5.7.2 Number of Children Being Vaccinated (Volume) 5.7.3 Market Size and Forecast (Value) 5.8 Hepatitis B 5.8.1 Doses Administered (Volume) 5.8.2 Number of Children Being Vaccinated (Volume) 5.8.3 Market Size and Forecast (Value) 5.9 Influenza Pediatric 5.9.1 Doses Administered (Volume) 5.9.2 Number of Children Being Vaccinated (Volume) 5.9.3 Market Size and Forecast (Value) 5.10 Measles, Mumps & Rubella (MMR) 5.10.1 Doses Administered (Volume) 5.10.2 Number of Children Being Vaccinated (Volume) 5.10.3 Market Size and Forecast (Value) 6. Key Companies Analysis 6.1 Sanofi Pasteur 6.1.1 Business Overview 6.1.2 Pediatric Vaccine Portfolios 6.1.3 Pedaitric Vaccine – Latest Development & Trends 6.2 GlaxoSmithKline (GSK) 6.2.1 Business Overview 6.2.2 Pediatric Vaccine Portfolios 6.2.3 Pediatric Vaccine – Latest Development & Trends 6.3 Merck & Co. 6.3.1 Business Overview 6.3.2 Pediatric Vaccine Portfolios 6.3.3 Pediatric Vaccine – Latest Development & Trends 6.4 Pfizer Inc. 6.4.1 Business Overview 6.4.2 Pediatric Vaccine Portfolios 6.4.3 Pediatric Vaccine – Latest Development & Trends 6.5 Grifols 6.5.1 Business Overview 6.5.2 Pediatric Vaccine Portfolios 6.5.3 Pediatric Vaccine – Latest Development & Trends |
List of Figures, Tables and Charts Available in United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024
List of Tables: Table 3–1: United States Pediatric Vaccines Market Share (Percent), 2010 – 2016 Table 3–2: United States Pediatric Vaccine Market Share Forecast (Percent), 2017 – 2024 |
List of Figures: Figure 2–1: United States Pediatric Vaccine Market (Million US$), 2010 – 2016 Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2017 – 2024 Figure 4–19: DTap Vaccine Doses Administered (in Million), 2010 – 2016 Figure 4–20: DTap Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–21: Number of Children Being Vaccinated with DTap Vaccine (in Million),2010 – 2016 Figure 4–22: Number of Children Being Vaccinated with DTap Vaccine Forecast (in Million),2017 – 2024 Figure 4–23: DTap Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–24: DTap Vaccine Market Value Forecast (in Million US$), 2017 – 2024 Figure 4–43: Hepatitis A Vaccine Doses Administered (in Million), 2010 – 2016 Figure 4–44: Hepatitis A Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–45: Number of Children Being Vaccinated with Hepatitis A Vaccine (in Million),2010 – 2016 Figure 4–46: Number of Children Being Vaccinated with Hepatitis A Vaccine Forecast (in Million),2017 – 2024 Figure 4–47: Hepatitis A Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–48: Hepatitis A Vaccine Market Value Forecast (in Million US$), 2017 – 2024 Figure 4–49: Varicella Vaccine Doses Administered (in Million), 2010–2016 Figure 4–50: Varicella Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–51: Number of Children Being Vaccinated with Varicella Vaccine (in Million),2010 – 2016 Figure 4–52: Number of Children Being Vaccinated with Varicella Vaccine Forecast (in Million),2017 – 2024 Figure 4–53: Varicella Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–54: Varicella Vaccine Market Value Forecast (in Million US$), 2017 – 2024 Figure 4–25: Pneumococcal Vaccine Doses Administered (in Million), 2010 – 2016 Figure 4–26: Pneumococcal Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–27: Number of Children Being Vaccinated with Pneumococcal Vaccine (in Million),2010 – 2016 Figure 4–28: Number of Children Being Vaccinated with Pneumococcal Vaccine Forecast (in Million),2017 – 2024 Figure 4–29: Pneumococcal Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–30: Pneumococcal Vaccine Market Value Forecast (in Million US$), 2017 – 2024 Figure 4–7: HIB Vaccine Doses Administered (in Million), 2010 – 2016 Figure 4–8: HIB Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–9: Number of Children Being Vaccinated with HIB Vaccine (in Million),2010 – 2016 Figure 4–10: Number of Children Being Vaccinated with HIB Vaccine Forecast (in Million),2017 – 2024 Figure 4–11: HIB Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–12: HIB Vaccine Market Value Forecast (in Million US$), 2017 – 2024 Figure 4–13: Polio Vaccine Doses Administered (in Million), 2010 – 2016 Figure 4–14: Polio Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–15: Number of Children Being Vaccinated with Polio Vaccine (in Million),2010 – 2016 Figure 4–16: Number of Children Being Vaccinated with Polio Vaccine Forecast (in Million),2017 – 2024 Figure 4–17: Polio Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–18: Polio Vaccine Market Value Forecast (in Million US$), 2017 – 2024 Figure 4–31: Rotavirus Vaccine Doses Administered (in Million), 2010 – 2016 Figure 4–32: Rotavirus Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–33: Number of Children Being Vaccinated with Rotavirus Vaccine (in Million),2010 – 2016 Figure 4–34: Number of Children Being Vaccinated with Rotavirus Vaccine Forecast (in Million),2017 – 2024 Figure 4–35: Rotavirus Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–36: Rotavirus Vaccine Market Value Forecast (in Million US$), 2017 – 2024 Figure 4–37: Hepatitis B Vaccine Doses Administered (in Million), 2010 – 2016 Figure 4–38: Hepatitis B Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–39: Number of Children Being Vaccinated with Hepatitis B Vaccine (in Million),2010 – 2016 Figure 4–40: Number of Children Being Vaccinated with Hepatitis B Vaccine Forecast (in Million),2017 – 2024 Figure 4–41: Hepatitis B Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–42: Hepatitis B Vaccine Market Value Forecast (in Million US$), 2017 – 2024 Figure 4–55: Influenza Pediatric Vaccine Doses Administered (in Million), 2010 – 2016 Figure 4–56: Influenza Pediatric Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–57: Number of Children Being Vaccinated with Influenza Pediatric Vaccine (in Million),2010 – 2016 Figure 4–58: Number of Children Being Vaccinated with Influenza Pediatric Vaccine Forecast (in Million),2017 – 2024 Figure 4–59: Influenza Pediatric Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–60: Influenza Pediatric Vaccine Market Value Forecast (in Million US$), 2017 – 2024 Figure 4–1: MMR Vaccine Doses Administered (in Million), 2010 – 2016 Figure 4–2: MMR Vaccine Doses Administered Forecast (in Million), 2017 – 2024 Figure 4–3: Number of Children Being Vaccinated with MMR Vaccine (in Million),2010 – 2016 Figure 4–4: Number of Children Being Vaccinated with MMR Vaccine Forecast (in Million),2017 – 2024 Figure 4–5: MMR Vaccine Market Value (in Million US$), 2010 – 2016 Figure 4–6: MMR Vaccine Market Value Forecast (in Million US$), 2017 – 2024 |
Keyplayers in United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024
Sanofi Pasteur, GlaxoSmithKline(GSK), Merck & Co., Pfizer Inc, Grifols |